Prospects of epigenetic therapy of head and neck squamous cell carcinoma
Introduction. Head and neck squamous cell carcinoma is the 6th most common malignant tumor. It is characterized by immune response evasion and drug resistance. To stimulate antitumor immune response, antibodies against such cell cycle checkpoints as programmed cell death 1 (pD-1) and programmed deat...
| Hlavní autor: | |
|---|---|
| Médium: | Článek |
| Jazyk: | Russian |
| Vydáno: |
ABV-press
2023-09-01
|
| Edice: | Опухоли головы и шеи |
| Témata: | |
| On-line přístup: | https://ogsh.abvpress.ru/jour/article/view/886 |